CIK 0001731348
- Large accelerated filer
Tilray Brands, Inc.
Sign in to watch- Ticker
- TLRY
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- May 31
- Entity type
- Operating
- EIN
- 824310622
- Phone
- +1 519-322-8800
- Business address
- 445 PARK AVENUE, NEW YORK, NY, 10022
- Former names
- Tilray, Inc.
- 4 Open-market sale Director sold 4,400 shares at $10.05 ($44,233)
- 4 Open-market sale Director sold 4,812 shares at $10.00 ($48,120)
- 4 Open-market sale President and CEO sold 400,000 shares at an average $7.43 ($2,973,568)
- 4 Open-market sale President and CEO sold 400,000 shares at $6.04 ($2,415,200)
- 4 Open-market sale President and CEO sold 400,000 shares at $5.60 ($2,238,560)
- 4 Open-market sale President and CEO sold 400,000 shares at $5.61 ($2,243,160)
- 4 Open-market sale President and CEO sold 400,000 shares at $5.83 ($2,331,320)
- 4 Option exercise Director acquired 2,188 shares (option exercise)
- 4 Shares withheld for taxes Chief Revenue Officer gave up 1,812 shares (to pay taxes)
- 4 Conversion President and CEO acquired 8,410,907 shares (conversion)
- 4 Option exercise Director acquired 30,696 shares (option exercise)
- 4 Open-market sale President and CEO sold 500,000 shares at $4.89 ($2,443,300)
- 4 Open-market sale President and CEO sold 500,000 shares at $5.13 ($2,567,050)
- 4 Open-market sale President and CEO sold 500,000 shares at $5.01 ($2,504,800)
- 4 Shares withheld for taxes Chief Corporate Dev Officer gave up 1,731 shares (to pay taxes)
- 4 Open-market sale Director sold 5,000 shares at $6.44 ($32,195)
- 4 Option exercise Director acquired 2,187 shares (option exercise)
- 4 Option exercise Director acquired 2,187 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 12 of 17 · 334 filings